Pharma Business Unit Lead | AI-Driven Growth & Scale
InstaLILY
New York (NY)
On-site
USD 150,000 - 200,000
Full time
14 days+
Application generator
Get a reply from this employer — a resume and cover letter tailored to exactly what they’re hiring for.
Get past ATS filters
Benefits offered by this job
Generous stock options
Wellness stipend
Parental leave
In-office lunch reimbursement
Job summary
InstaLILY is looking for an experienced leader to serve as the CEO of our Pharma business unit. This role is pivotal in scaling existing operations while leveraging proven product-market fit. The ideal candidate will have 8–12+ years in the Pharma industry, strong operational scaling capabilities, and the ability to influence at the executive level. You'll directly collaborate with the CEO and COO to shape strategic initiatives. The compensation includes a salary range of $150,000 - $200,000 per year along with attractive equity options and comprehensive benefits.
Qualifications
8–12+ years in Pharma, particularly in Commercial Ops or Supply Chain.
Demonstrated experience in scaling successful concepts.
Ability to engage and influence C-suite executives.
Understanding of AI's impact in the industry.
Responsibilities
Grow existing vertical and secure key accounts.
Create a scalable playbook for Pharma.
Act as an intermediary between customers and product teams.
Own the success outcomes for the Pharma vertical.
Skills
Pharma industry experience
Sales and operations scaling
Executive presence
Digital transformation knowledge
Job description
InstaLILY is looking for an experienced leader to serve as the CEO of our Pharma business unit. This role is pivotal in scaling existing operations while leveraging proven product-market fit. The ideal candidate will have 8–12+ years in the Pharma industry, strong operational scaling capabilities, and the ability to influence at the executive level. You'll directly collaborate with the CEO and COO to shape strategic initiatives. The compensation includes a salary range of $150,000 - $200,000 per year along with attractive equity options and comprehensive benefits.